Kidney cancer treatment and research at Dana-Farber
More than 36,000 cases of kidney cancer are expected to be diagnosed in the U.S. in 2005, according to the American Cancer Society (ACS). The ACS projects that more than 12,600 kidney cancer patients will die from the disease this year.
Dana-Farber's Lank Center for Genitourinary Oncology is a multidisciplinary and multispecialty care and treatment center, as well as a cutting-edge research facility. Their focus is to provide expert, compassionate, and state-of-the-art care, as well as to offer patients options that include experimental treatments. They treat all genitourinary malignancies, including cancers of the prostate, testes, bladder and kidney.
